Point: The Reporting of Estimated Glucose with Hemoglobin A1c

Point: The reporting of estimated glucose with hemoglobin A1c.

Healthcare providers and patients with diabetes evaluate the efficacy of glycemic control by 2 strategies. One strategy involves self-monitoring of blood glucose (SMBG) by patients, with portable meters and continuous blood glucose monitors or sensing devices. Patients use these glucose values for daily decisionmaking to adjust medication doses and/or modify food intake or exercise regimens. Bl...

The Reporting of Estimated Glucose with Hemoglobin A1c

Hemoglobin A1c (Hb A1c) 2 is a key parameter for understanding glycemic control in diabetes. It is used by both clinicians and patients to trigger adjustments in behavior and treatment. In general, clinicians understand Hb A1c and its limitations well, but evidence suggests that patients have difficulty understanding what Hb A1c means and how it relates to glucose. This situation may be particu...

The Reporting of Estimated Glucose with Hemoglobin A1c

Healthcare providers and patients with diabetes evaluate the efficacy of glycemic control by 2 strategies. One strategy involves self-monitoring of blood glucose (SMBG) by patients, with portable meters and continuous blood glucose monitors or sensing devices. Patients use these glucose values for daily decisionmaking to adjust medication doses and/or modify food intake or exercise regimens. Bl...

Reporting hemoglobin A1c: do the units matter?

Hemoglobin A1c (Hb A1c) 2 is the analyte most commonly measured in clinical laboratories for patients with diabetes mellitus. Physicians use Hb A1c to monitor long-term glycemic control, adjust therapy, and predict complications of diabetes. Recently, Hb A1c was added as a criterion for the diagnosis of diabetes. Unlike most analytes, many patients with diabetes know their Hb A1c value and are ...

Assessing the performance of point-of-care hemoglobin A1c systems.